Resultado da Busca
31 de mai. de 2024 · Our analysis of changes in the cell therapy landscape over the past five years shows that the number of new trials peaked in 2021 and has since decreased by 3.9% in 2022 (led by a 10.5% reduction ...
Há 5 dias · Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.
- Curr Cancer Drug TargetsCURR CANCER DRUG TAR
- Current Cancer Drug Targets
2 de jun. de 2024 · Osimertinib is a recommended treatment for advanced non–small-cell lung cancer (NSCLC) with an epidermal growth factor receptor ( EGFR) mutation and as adjuvant treatment for resected EGFR...
29 de mai. de 2024 · Elaine Schattner. Over the past decade, the variety and therapeutic potential of cancer medicines have escalated significantly 1. New classes of treatment are prolonging the lives of many people...
Há 4 dias · Introduction. Gastric cancer (GC) is a leading cause of cancer-related deaths globally 1, 2. Its occurrence, development, and prognosis are influenced by various complex factors and...
Há 3 dias · Background Novel antibody-drug conjugates (ADCs) drugs present a promising anti-cancer treatment, although survival benefits for HER2-positive advanced breast cancer (BC) remain controversial. The aim of this meta-analysis was to evaluate the comparative effect of ADCs and other anti-HER2 therapy on progression-free survival (PFS) and overall survival (OS) for treatment of HER2-positive ...
15 de mai. de 2024 · According to the analyses using the Global Cancer Observatory 2020 (GLOBOCAN), there were an estimated 19.3 million new cancer cases worldwide in 2020, and almost 10.0 million people died due to this disease [ 1 ]. Breast cancer in women and lung, colon, prostate, and stomach cancers were the most common ones [ 2 ].
